Abstract
Viele Wissenschaftler sind sich über die Machbarkeit einer komplexen zweistufigen Therapie für CE einig [10, 16, 23, 25, 26]. Der erste Schritt besteht darin, den Infektionserreger aus der Gebärmutterschleimhaut zu eliminieren, was durch die Verschreibung von Breitbandantibiotika erreicht wird, die hauptsächlich gegen UPM gerichtet sind. In einer randomisierten, placebokontrollierten Studie haben W. Andrews et al. [27] analysierten die dynamischen Veränderungen in der Zusammensetzung von Mikroorganismen im Endometrium bei Patienten, die eine AB-Behandlung erhielten und nicht erhielten. Die Autoren bestätigten, dass die Einführung von AB-Medikamenten die Eliminierung von Krankheitserregern aus dem Endometrium erheblich sicherstellt: UPM vor der Behandlung in 86 % der Fälle, dann in 37 % (p<0,05), ohne Behandlung lagen diese Indikatoren bei 91 und 60. % (p>0,05) bzw. E. Cicinelli und andere. [28] Nach der Durchführung einer Hysteroskopie und der Verschreibung einer AB-Therapie bei Patientinnen mit histologisch bestätigtem CE zeigten 71 % der Frauen eine vollständige Normalisierung der hysteroskopischen und morphologischen Bilder des Endometriums, und UPM konnte aus der Gebärmutterhöhle entfernt werden. 78,4 % der Patientinnen dieser Gruppe wurden anschließend schwanger. Die Autoren kamen zu dem Schluss, dass eine Antibiotikabehandlung bei CE positive Auswirkungen auf die Eliminierung von Mikroorganismen aus dem Endometrium und die Verbesserung der Fortpflanzungsergebnisse hat.
References
Andryev S. et al. Experience with the use of memantine in the treatment of cognitive disorders //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 282-288.
Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood lymphocytes with a risk of developing antipsychotic extrapyramidal diseases //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 29-35.
Asanova R. et al. Features of the treatment of patients with mental disorders and cardiovascular pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 545-550.
Begbudiyev M. et al. Integration of psychiatric care into primary care //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 551-557.
Bo’Riyev B. et al. Features of clinical and psychopathological examination of young children //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 558-563.
Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 36-41.
Ivanovich U. A. et al. Efficacy and tolerance of pharmacotherapy with antidepressants in non-psychotic depressions in combination with chronic brain ischemia //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 409-414.
Nikolaevich R. A. et al. Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 898-903.
Novikov A. et al. Alcohol dependence and manifestation of autoagressive behavior in patients of different types //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 413-419.
Pachulia Y. et al. Assessment of the effect of psychopathic disorders on the dynamics of withdrawal syndrome in synthetic cannabinoid addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 240-244.
Pachulia Y. et al. Neurobiological indicators of clinical status and prognosis of therapeutic response in patients with paroxysmal schizophrenia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 385-391.
Pogosov A. et al. Multidisciplinary approach to the rehabilitation of patients with somatized personality development //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 245-251.
Pogosov A. et al. Rational choice of pharmacotherapy for senile dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 230-235.
Pogosov S. et al. Gnostic disorders and their compensation in neuropsychological syndrome of vascular cognitive disorders in old age //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 258-264.
Pogosov S. et al. Prevention of adolescent drug abuse and prevention of yatrogenia during prophylaxis //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 392-397.
Pogosov S. et al. Psychogenetic properties of drug patients as risk factors for the formation of addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 186-191.
Prostyakova N. et al. Changes in the postpsychotic period after acute polymorphic disorder //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 356-360.
Prostyakova N. et al. Issues of professional ethics in the treatment and management of patients with late dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 158-165.
Prostyakova N. et al. Sadness and loss reactions as a risk of forming a relationship together //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 252-257.
Prostyakova N. et al. Strategy for early diagnosis with cardiovascular diseaseisomatized mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 166-172.
Rotanov A. et al. Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 267-272.
Rotanov A. et al. Diagnosis of depressive and suicidal spectrum disorders in students of a secondary special education institution //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 309-315.
Rotanov A. et al. Elderly epilepsy: neurophysiological aspects of non-psychotic mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 192-197.
Rotanov A. et al. Social, socio-cultural and behavioral risk factors for the spread of hiv infection //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 49-55.
Rotanov A. et al. Suicide and epidemiology and risk factors in oncological diseases //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 398-403.
Sedenkov V. et al. Clinical and socio-demographic characteristics of elderly patients with suicide attempts //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 273-277.
Sedenkov V. et al. Modern methods of diagnosing depressive disorders in neurotic and affective disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 361-366.
Sedenkova M. et al. Basic principles of organizing gerontopsychiatric assistance and their advantages //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 63-69.
Sedenkova M. et al. Features of primary and secondary cognitive functions characteristic of dementia with delirium //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 56-62.
Sedenkova M. et al. The possibility of predicting the time of formation and development of alcohol dependence: the role of genetic risk, family weight and its level //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 173-178.
Shamilov V. et al. Disorders of decision-making in the case of depression: clinical evaluation and correlation with eeg indicators //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 198-204.
Solovyova Y. et al. Protective-adaptive complexes with codependency //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 70-75.
Solovyova Y. et al. Suicide prevention in adolescents with mental disorders //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 303-308.
Solovyova Y. et al. The relevance of psychotic disorders in the acute period of a stroke //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 212-217.
Spirkina M. et al. Integrated approach to correcting neurocognitive defects in schizophrenia //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 76-81.